GSO ASTM E734:2021

ASTM E734:80(2015)
Gulf Standard   Current Edition · Approved on 01 July 2021

Standard Specification for Disposable Glass Blood Sample Capillary Tube (Microhematocrit)

GSO ASTM E734:2021 Files

English 3 Pages
Current Edition Reference Language

GSO ASTM E734:2021 Scope

This specification describes the physical requirements and corresponding test methods for disposable glass blood sample capillary tubes for use in microhematocrit procedures. Covered here are two different types of capillary tubes, namely, Type I (coated with heparin), and Type II (uncoated). The tubes shall be fabricated from Type I, Class B borosilicate glass, or Type II soda lime glass. Conversely, the heparin used for coating Type I tubes shall be of ammonium salt isolated from the lungs or intestinal mucosa of beef or pork origin. The tubes shall conform to specified requirements for design, dimension, workmanship, color coding, and lot or control number. They should also pass the following tests for capillarity, fluidity, sheep plasma, positive and negative controls, human whole blood, heparin potency assay, and resistance to centrifugal force.

Best Sellers From Health Sector

GSO 2017:2023
 
Gulf Standard
Personal Care and Baby Wet Wipes
GSO 2241:2023
 
Gulf Standard
Cosmetic Products - Body Cleaners
GSO 2063:2023
 
Gulf Standard
Cosmetic Products - Hair Conditioner (Balsam)
GSO 1223:2023
 
Gulf Standard
Cosmetic Products-Deodorants

Recently Published from Health Sector

GSO ISO 11608-7:2024
ISO 11608-7:2016 
Gulf Standard
Needle-based injection systems for medical use — Requirements and test methods — Part 7: Accessibility for persons with visual impairment
GSO ISO/TR 24666:2024
ISO/TR 24666:2023 
Gulf Standard
Sports and recreational facilities — Probes for entrapment/entanglement on playground equipment — Collection of data
GSO ISO 9713:2024
ISO 9713:2022 
Gulf Standard
Neurosurgical implants — Self-closing intracranial aneurysm clips
GSO ISO/TS 22690:2024
ISO/TS 22690:2021 
Gulf Standard
Genomics informatics — Reliability assessment criteria for high-throughput gene-expression data